Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | roundabout 2 | 0.035 | 0.3922 | 0.3922 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0228 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0417 | 0.6078 | 1 |
Trypanosoma cruzi | Fibronectin type III domain containing protein, putative | 0.0228 | 0 | 0.5 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.029 | 0.1982 | 0.326 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0317 | 0.2866 | 0.4715 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0288 | 0.194 | 0.3192 |
Schistosoma mansoni | receptor tyrosine phosphatase type r2a | 0.035 | 0.3922 | 0.4866 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0288 | 0.194 | 0.3192 |
Trypanosoma cruzi | Fibronectin type III domain containing protein, putative | 0.0228 | 0 | 0.5 |
Loa Loa (eye worm) | CAMK protein kinase | 0.0288 | 0.194 | 0.3192 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.035 | 0.3922 | 0.6452 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.035 | 0.3922 | 0.6452 |
Loa Loa (eye worm) | hypothetical protein | 0.031 | 0.2643 | 0.4349 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.0288 | 0.194 | 0.194 |
Schistosoma mansoni | myosin-binding protein-related | 0.0288 | 0.194 | 0.2407 |
Echinococcus multilocularis | roundabout 2 | 0.0538 | 1 | 1 |
Echinococcus granulosus | nephrin | 0.0288 | 0.194 | 0.194 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.025 | 0.0703 | 0.0703 |
Onchocerca volvulus | 0.0288 | 0.194 | 1 | |
Brugia malayi | hypothetical protein | 0.0417 | 0.6078 | 1 |
Echinococcus granulosus | titin | 0.0288 | 0.194 | 0.194 |
Schistosoma mansoni | ephrin receptor | 0.0295 | 0.2163 | 0.2684 |
Schistosoma mansoni | cell adhesion molecule | 0.0288 | 0.194 | 0.2407 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0417 | 0.6078 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0478 | 0.806 | 1 |
Trypanosoma brucei | Fibronectin type III domain containing protein, putative | 0.0228 | 0 | 0.5 |
Echinococcus multilocularis | neuroglian | 0.035 | 0.3922 | 0.3922 |
Echinococcus multilocularis | transfer RNA-Phe | 0.0288 | 0.194 | 0.194 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0288 | 0.194 | 0.3192 |
Echinococcus granulosus | Down syndrome cell adhesion molecule | 0.029 | 0.1982 | 0.1982 |
Loa Loa (eye worm) | hypothetical protein | 0.0417 | 0.6078 | 1 |
Schistosoma mansoni | hemicentin | 0.0288 | 0.194 | 0.2407 |
Echinococcus multilocularis | neuroglian | 0.0249 | 0.0662 | 0.0662 |
Echinococcus granulosus | roundabout 2 | 0.035 | 0.3922 | 0.3922 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0295 | 0.2163 | 0.2163 |
Schistosoma mansoni | cell adhesion molecule | 0.035 | 0.3922 | 0.4866 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.035 | 0.3922 | 0.6452 |
Schistosoma mansoni | titin | 0.0288 | 0.194 | 0.2407 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0288 | 0.194 | 0.2407 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0288 | 0.194 | 0.3192 |
Echinococcus granulosus | neuroglian | 0.035 | 0.3922 | 0.3922 |
Schistosoma mansoni | cell adhesion molecule | 0.035 | 0.3922 | 0.4866 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.035 | 0.3922 | 0.3922 |
Onchocerca volvulus | 0.0288 | 0.194 | 1 | |
Brugia malayi | protein unc-22 | 0.0288 | 0.194 | 0.3192 |
Loa Loa (eye worm) | hypothetical protein | 0.0288 | 0.194 | 0.3192 |
Echinococcus granulosus | titin | 0.0288 | 0.194 | 0.194 |
Loa Loa (eye worm) | hypothetical protein | 0.031 | 0.2643 | 0.4349 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.035 | 0.3922 | 0.6452 |
Schistosoma mansoni | hypothetical protein | 0.0288 | 0.194 | 0.2407 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase F | 0.035 | 0.3922 | 0.3922 |
Echinococcus multilocularis | Down syndrome cell adhesion molecule | 0.029 | 0.1982 | 0.1982 |
Loa Loa (eye worm) | CAMK/MLCK protein kinase | 0.0288 | 0.194 | 0.3192 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0317 | 0.2866 | 0.4715 |
Schistosoma mansoni | nephrin | 0.0477 | 0.8018 | 0.9949 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0288 | 0.194 | 0.3192 |
Schistosoma mansoni | nephrin | 0.035 | 0.3922 | 0.4866 |
Echinococcus multilocularis | roundabout 2 | 0.035 | 0.3922 | 0.3922 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0288 | 0.194 | 0.3192 |
Schistosoma mansoni | cell adhesion molecule | 0.0288 | 0.194 | 0.2407 |
Echinococcus granulosus | twitchin | 0.0249 | 0.0662 | 0.0662 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.035 | 0.3922 | 0.3922 |
Echinococcus granulosus | neuroglian | 0.0249 | 0.0662 | 0.0662 |
Loa Loa (eye worm) | hypothetical protein | 0.0417 | 0.6078 | 1 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.035 | 0.3922 | 0.3922 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.029 | 0.1982 | 0.326 |
Schistosoma mansoni | titin | 0.0288 | 0.194 | 0.2407 |
Echinococcus multilocularis | contactin neuroglian septate junction protein | 0.035 | 0.3922 | 0.3922 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0288 | 0.194 | 0.3192 |
Schistosoma mansoni | neuroglian | 0.035 | 0.3922 | 0.4866 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0295 | 0.2163 | 0.2163 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0417 | 0.6078 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.035 | 0.3922 | 0.6452 |
Loa Loa (eye worm) | hypothetical protein | 0.0288 | 0.194 | 0.3192 |
Leishmania major | hypothetical protein, conserved | 0.0228 | 0 | 0.5 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0288 | 0.194 | 0.3192 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.035 | 0.3922 | 0.6452 |
Onchocerca volvulus | 0.0288 | 0.194 | 1 | |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0288 | 0.194 | 0.3192 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0288 | 0.194 | 0.3192 |
Loa Loa (eye worm) | projectin | 0.0288 | 0.194 | 0.3192 |
Echinococcus multilocularis | titin | 0.0288 | 0.194 | 0.194 |
Loa Loa (eye worm) | hypothetical protein | 0.025 | 0.0703 | 0.1156 |
Echinococcus granulosus | contactin | 0.035 | 0.3922 | 0.3922 |
Echinococcus granulosus | roundabout 2 | 0.035 | 0.3922 | 0.3922 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.3109 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.